Literature DB >> 25540740

Gene transfer to human trabecular meshwork cells in vitro and ex vivo using HIV-based lentivirus.

Yan Xiang1, Bin Li1, Jun-Ming Wang1, Gui-Gang Li1, Hong Zhang1, Anne Manyande2, Xue-Bi Tian3.   

Abstract

AIM: To investigate whether the enhanced green fluorescent protein (EGFP) reporter gene could be transferred into human trabecular meshwork (HTM) cells by a HIV-based lentivirus both in vitro and ex vivo.
METHODS: The HIV-based lentivirus that contains an EF1-α promoter driving EGFP expression cassette was constructed following the standard molecular cloning methods. The cultured HTM cells were transduced at a range of multiplicity of infection (MOI) with HIV-based lentivirus. EGFP positive cell populations were detected by flow cytometry. Human anterior eye segments were cultured with perfusion culture system and transfected by HIV-based lentivirus with a 1×10(8) transducing unit (TU) virus in perfusion liquid. The intraocular pressure was recorded every 8h for 21d. The expression of EGFP in the anterior segment of the human eye was detected by fluorescence microscopy. Furthermore, the distribution of EGFP expression was confirmed by anti-EGFP immunohistochemical staining.
RESULTS: The HIV-based lentivirus which contains an EF1-α promoter driving EGFP expression cassette was constructed successfully. After HTM cells were transduced with HIV-based lentivirus containing EGFP in vitro, the ratio of EGFP positive cells to the total cell number reached 92.3%, with the MOI of 15. After the lentivirus containing EGFP were used to transduce human anterior eye segments, the EGFP could be directly detected by fluorescence microscopy in vivo. Immunohistochemistry staining revealed that 88.19% EGFP-positive trabecular meshwork (TM) cells were observed in the human anterior segment. Nevertheless, the intraocular pressure in the lentivirus-transduced group kept constant when compared with control group (P>0.05).
CONCLUSION: EGFP gene could be efficiently transferred into HTM cells both in vitro and ex vivo by using HIV-based lentivirus.

Entities:  

Keywords:  HIV-based lentivirus; gene transfer; glaucoma; trabecular meshwork

Year:  2014        PMID: 25540740      PMCID: PMC4270982          DOI: 10.3980/j.issn.2222-3959.2014.06.02

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  20 in total

Review 1.  The changing conceptual basis of trabeculectomy: a review of past and current surgical techniques.

Authors:  M Reza Razeghinejad; Scott J Fudemberg; George L Spaeth
Journal:  Surv Ophthalmol       Date:  2012 Jan-Feb       Impact factor: 6.048

2.  Advances in glaucoma treatment and management: gene therapy.

Authors:  Terete Borrás
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

Review 3.  Trabecular meshwork as a new target for the treatment of glaucoma.

Authors:  Elisa Ferrer
Journal:  Drug News Perspect       Date:  2006-04

4.  Genetic modification of human trabecular meshwork with lentiviral vectors.

Authors:  N Loewen; M P Fautsch; M Peretz; C K Bahler; J D Cameron; D H Johnson; E M Poeschla
Journal:  Hum Gene Ther       Date:  2001-11-20       Impact factor: 5.695

5.  Mechanisms of AAV transduction in glaucoma-associated human trabecular meshwork cells.

Authors:  Teresa Borrás; Wei Xue; Vivian W Choi; Jeffrey S Bartlett; Guorong Li; Richard J Samulski; Sarah S Chisolm
Journal:  J Gene Med       Date:  2006-05       Impact factor: 4.565

6.  An improved tet-on system for gene expression in neurons delivered by a single lentiviral vector.

Authors:  Xuebi Tian; Gongming Wang; Ying Xu; Ping Wang; Shasha Chen; Hui Yang; Feng Gao; Aijun Xu; Fei Cao; Xiaogao Jin; Anne Manyande; Yuke Tian
Journal:  Hum Gene Ther       Date:  2009-02       Impact factor: 5.695

7.  Gene expression profile in human trabecular meshwork from patients with primary open-angle glaucoma.

Authors:  Yutao Liu; R Rand Allingham; Xuejun Qin; David Layfield; Andrew E Dellinger; Jason Gibson; Joshua Wheeler; Allison E Ashley-Koch; W Daniel Stamer; Michael A Hauser
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-27       Impact factor: 4.799

Review 8.  Gene therapy for glaucoma.

Authors:  Anna-Maria Demetriades
Journal:  Curr Opin Ophthalmol       Date:  2011-03       Impact factor: 3.761

9.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

10.  Durable, safe, multi-gene lentiviral vector expression in feline trabecular meshwork.

Authors:  Pranay D Khare; Nils Loewen; Wulin Teo; Román A Barraza; Dyana T Saenz; Douglas H Johnson; Eric M Poeschla
Journal:  Mol Ther       Date:  2007-10-02       Impact factor: 11.454

View more
  4 in total

1.  A Novel Mouse Model of TGFβ2-Induced Ocular Hypertension Using Lentiviral Gene Delivery.

Authors:  Shruti V Patil; Ramesh B Kasetti; J Cameron Millar; Gulab S Zode
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

2.  Capsid Mutated Adeno-Associated Virus Delivered to the Anterior Chamber Results in Efficient Transduction of Trabecular Meshwork in Mouse and Rat.

Authors:  Barbara Bogner; Sanford L Boye; Seok Hong Min; James J Peterson; Qing Ruan; Zhonghong Zhang; Herbert A Reitsamer; William W Hauswirth; Shannon E Boye
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

3.  C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey.

Authors:  Junkai Tan; Xizhen Wang; Suping Cai; Fen He; Daren Zhang; Dongkan Li; Xianjun Zhu; Liang Zhou; Ning Fan; Xuyang Liu
Journal:  Mol Ther Methods Clin Dev       Date:  2019-11-29       Impact factor: 6.698

4.  Long-Term Decrease of Intraocular Pressure in Rats by Viral Delivery of miR-146a.

Authors:  Coralia Luna; Megan Parker; Pratap Challa; Pedro Gonzalez
Journal:  Transl Vis Sci Technol       Date:  2021-07-01       Impact factor: 3.283

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.